Kim Hyun-tae
$1.0B
Born
Mar 11, 1976
Age
49
Source of Wealth
Biotech
Residence
Incheon,
Citizenship
Marital Status
Children
0
Education
- Kim Hyun-tae is CEO of South Korean biotechnology company Voronoi.
- Voronoi's two most promising cancer drug candidates are VRN10 and VRN11. Both started Phase 1 clinical trials in the first quarter of 2025.
- Voronoi was founded by Kim's younger brother, Hyun-seok, in 2015. The older Kim took over the company in 2016 and listed it on Korea's Kosdaq in 2022.
- Previously, Kim did stints as head of asset management at eBest Investment & Securities, Hanwha Investment & Securities and KB Securities.
| Exchange | Ticker | Company Name | Number Of Shares | Share Price | Currency Code |
|---|